DoD Prostate Cancer, Clinical Trial Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Prostate Cancer, Clinical Trial Award

The intent of the PCRP Clinical Trial Award (CTA) is to accelerate the development of new interventions to decrease the burden of prostate cancer by supporting the rapid implementation of early-phase clinical trials ( Ph...

61
match
Deadline 2529 days ago Location Alabama Type grant Level Federal Closed posted May 3, 2019
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$12,800,000.
  • Next deadline: July 18, 2019.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
Sign in to generate AI summary
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Deadline
2529 days ago
Jul 18, 2019
Total pool
$12.8M

About this opportunity

The intent of the PCRP Clinical Trial Award (CTA) is to accelerate the development of new interventions to decrease the burden of prostate cancer by supporting the rapid implementation of early-phase clinical trials ( Phase 0, Phase I, pilot Phase II). Therapeutic approaches proposed for testing through the CTA may include novel interventions or the testing of existing interventions for new indications in prostate cancer, but must represent hypothesis-based approaches for the treatment of prostate cancer that will have a major impact on one or more of the FY19 PCRP Overarching Challenges. Interventions may include radionuclides, surgical procedures, behavior modifications, or other types of interventions based on investigator discretion. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform prostate cancer patient care. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. Projects funded by the CTA are expected to facilitate the rapid implementation of early-phase clinical trials ( Phase 0, Phase I, pilot Phase II). New FY19 definition: A clinical trial is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/ Examples of acceptable studies include, but are not limited to, the following: • Studies designed to identify an appropriate population or subpopulation for future clinical trials. • Identification of the dosage, duration, and/or delivery strategy of an intervention. • Evaluation of the feasibility of the intervention in prostate cancer. • Evaluation of efficacy and safety of the intervention. If the proposed clinical trial involves the use of a drug that has not been approved by the Food and Drug Administration (FDA) for the proposed investigational use, then an Investigational New Drug (IND) application to the FDA that meets all requirements under the Code of Federal Regulations, Title 21, Part 312 (21 CFR 312) may be required. It is the responsibility of the applicant to provide evidence from the Institutional Review Board (IRB) of record or the FDA if an IND is not required. If an IND is required, the IND application must be approved by the FDA by the Clinical Trial Award application submission deadline. The IND should be specific for the product ( the product should not represent a derivative or alternate version of the investigational agent described in the IND application) and indication to be tested in the proposed clinical trial. For more information on IND applications, the FDA has provided guidance at https://www.fda.gov/drugs/developmentapprovalprocess/ howdrugsaredevelopedandapproved/approvalapplications/investigationalnewdrugindapplication/ If the investigational product is a device, then an Investigational Device Exemption (IDE) application to the FDA that meets all requirements under 21 CFR 812 may be required. It is the responsibility of the applicant to provide evidence from the IRB of record, or from the FDA if an IDE is not required or if the device qualifies for an abbreviated IDE. If an IDE is required, the IDE application must be approved by the FDA by the Clinical Trial Award application submission deadline. The IDE should be specific for the device ( should not represent a derivative or modified version of the device described in the IDE application) and indication to be tested in the proposed clinical trial. Refer to Attachment 10, Regulatory Strategy, for additional details on documentation of FDA applications.

Funding agency

Defense Health Agency Contracting Activity - DHACA
Federal agency

Tags

Healthcare & Biotech Manufacturing Arts & Culture Education & Research Veterans Transportation & Logistics Science, Tech & Engineering (STEM)
Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID315598
PostedMay 3, 2019

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.

Similar grants

Construction & Housing
Transportation Department

Notice of Funding Opportunity for the Fiscal Year 2025 and 2026 Consolidated Rail Infrastructure and Safety Improvements Program

83
match

- **Who can apply:** Federal-level applicants (see eligibility for details). - **Issued by:** Transportation Department. - **About:** The Federal Railroad Administration has published a Notice of Funding Opportunity (…

Amount varies Rolling Nationwide, USA
Transportation & Logistics
Transportation Department

Notice of Funding Opportunity for the Fiscal Years 2025-2026 Federal-State Partnership for Intercity Passenger Rail Program for Projects Located on the Northeast Corridor (Partnership-NEC)

97
match

- **Who can apply:** Federal-level applicants (see eligibility for details). - **Issued by:** Transportation Department. - **About:** The Federal Railroad Administration has published a Notice of Funding Opportunity (…

Amount varies Rolling Nationwide, USA
Agriculture & Farming
Department of Resources Recycling and Recovery

Farm and Ranch Solid Waste Cleanup and Abatement Grant Program FR91

71
match

Purpose: The Farm & Ranch Solid Waste Clean Up & Abatement Grant program provides funding for cleaning up and preventing illegal dumping on agricultural properties (CCR, Section 17991(d)). Each fiscal year has four ap…

Amount varies Rolling California, USA
Nonprofit & Community
CA State Library

2026-2027 LSTA Digital Literacy and Access

68
match

Purpose: Public libraries provide access to digital resources and the skills to safely use those resources, which are key components of the Broadband for All Initiative . The goals of this opportunity are to help libr…

Amount varies Rolling California, USA
Apply on agency site